Literature DB >> 8187639

Pax-2 is required for mesenchyme-to-epithelium conversion during kidney development.

U W Rothenpieler1, G R Dressler.   

Abstract

The conversion of mesenchyme to epithelium during the embryonic development of the mammalian kidney requires reciprocal inductive interactions between the ureter and the responding metanephric mesenchyme. The Pax-2 gene is activated in the mesenchyme in response to induction and is subsequently down-regulated in more differentiated cells derived from the mesenchyme. Pax-2 belongs to a family of genes, at least three of which encode morphogenetic regulatory transcription factors. In order to determine the role of Pax-2 during kidney development, we have generated a loss-of-function phenotype using antisense oligonucleotides in mouse kidney organ cultures. These oligonucleotides can specifically inhibit Pax-2 protein accumulation in kidney mesenchyme cells, where the intracellular concentrations are maximal. The kidney organ cultures were stained with uvomurulin and laminin antibodies as markers for epithelium formation. With significantly reduced Pax-2 protein levels, kidney mesenchyme cells fail to aggregate and do not undergo the sequential morphological changes characteristic of epithelial cell formation. The data demonstrate that Pax-2 function is required for the earliest phase of mesenchyme-to-epithelium conversion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8187639     DOI: 10.1242/dev.119.3.711

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  60 in total

1.  PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin.

Authors:  M S Lechner; I Levitan; G R Dressler
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

2.  Nephric lineage specification by Pax2 and Pax8.

Authors:  Maxime Bouchard; Abdallah Souabni; Markus Mandler; Annette Neubüser; Meinrad Busslinger
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

Review 3.  Water-clear parathyroid adenoma: report of two cases and literature review.

Authors:  Shuting Bai; Virginia A LiVolsi; Douglas L Fraker; Zhanyong Bing
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

4.  Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Authors:  Sylvia Hilliard; Karam Aboudehen; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2011-03-21       Impact factor: 3.582

Review 5.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

6.  Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.

Authors:  Valentina Fonsato; Stefano Buttiglieri; Maria Chiara Deregibus; Valeria Puntorieri; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

7.  Antisense oligonucleotides to Cux-1, a Cut-related homeobox gene, cause increased apoptosis in mouse embryonic kidney cultures.

Authors:  S E Quaggin; H Yeger; P Igarashi
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

8.  Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys.

Authors:  R Attar; F Quinn; P J Winyard; P D Mouriquand; P Foxall; M A Hanson; A S Woolf
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

9.  Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds.

Authors:  Edward A Ross; Matthew J Williams; Takashi Hamazaki; Naohiro Terada; William L Clapp; Christopher Adin; Gary W Ellison; Marda Jorgensen; Christopher D Batich
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

Review 10.  Patterning and early cell lineage decisions in the developing kidney: the role of Pax genes.

Authors:  Gregory R Dressler
Journal:  Pediatr Nephrol       Date:  2011-01-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.